APA (7th ed.) Citation

S, N., T, P., G, D., MM, S., P, D., H, W., . . . SJ, S. (2021). Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021. MMWR. Morbidity and mortality weekly report, 70(34), 1163. https://doi.org/10.15585/mmwr.mm7034e3

Chicago Style (17th ed.) Citation

S, Nanduri, et al. "Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021." MMWR. Morbidity and Mortality Weekly Report 70, no. 34 (2021): 1163. https://doi.org/10.15585/mmwr.mm7034e3.

MLA (9th ed.) Citation

S, Nanduri, et al. "Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021." MMWR. Morbidity and Mortality Weekly Report, vol. 70, no. 34, 2021, p. 1163, https://doi.org/10.15585/mmwr.mm7034e3.